Regina Groves

Regina Groves

Director/Board Member at ATRICURE, INC.

Net worth: 2 M $ as of 2026-05-30

67 year
Health Technology
Consumer Services
Process Industries

Profile

Ms. Regina E.
Groves
is an Independent Director at Fulgent Genetics, Inc. and an Independent Director at AtriCure, Inc. She is on the Board of Directors at Fulgent Genetics, Inc., Advanced Nanotherapies, Inc., AtriCure, Inc. and Stimwave Technologies, Inc. Ms. Groves was previously employed as a Chief Executive Officer & Director by REVA Medical, Inc., a Chairman by Foxcroft School, a Vice President & General Manager by AF Solutions Holdings LLC, and a Vice President-Quality & Regulatory CRDM by Medtronic, Inc. She also served on the board at Stimwave LLC.
She received her undergraduate degree from the University of Florida and an MBA from Harvard Graduate School of Education.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-17 39,859 ( 0.08% ) 1 M $ 2026-05-30
2026-05-13 28,099 ( 0.09% ) 509 716 $ 2026-05-30

Regina Groves active positions

CompaniesPositionStart
ATRICURE, INC. Director/Board Member 2017-03-20
FULGENT GENETICS, INC. Director/Board Member 2023-01-02
Director/Board Member -
Director/Board Member 2020-08-31

Former positions of Regina Groves

CompaniesPositionEnd
Director of Finance/CFO 2020-11-30
REVA MEDICAL INC Chief Executive Officer 2019-03-24
Chairman 2015-12-31
Corporate Officer/Principal 2007-12-31
Corporate Officer/Principal -
See the detail of Regina Groves's experience

Training of Regina Groves

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Process Industries

Health Services

Health Technology

Health Technology